Hemophilia. Current concepts in management.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001803:Blood Transfusion; D002318:Cardiovascular Diseases / Q000150:complications; D002648:Child; D003276:Contraceptives, Oral / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000150:complications; D006395:Hemarthrosis / Q000628:therapy; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D002836:Hemophilia B / Q000188:drug therapy; D006470:Hemorrhage / Q000517:prevention & control; D006701:Home Nursing; D006801:Humans; D007239:Infections / Q000150:complications; D001239:Inhalation; D009422:Nervous System Diseases / Q000150:complications; D012917:Social Adjustment; D013974:Thyroxine / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use; D014570:Urologic Diseases / Q000150:complications; D014667:Vasopressins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000933:Antifibrinolytic Agents; D003276:Contraceptives, Oral; D004967:Estrogens; D014284:Triiodothyronine; D014667:Vasopressins; D005169:Factor VIII; D005164:Factor IX; D013974:Thyroxine